Wearable Data for Personalized Prognostication in Cancer: A Registry Protocol
- Sponsor
- City of Hope Medical Center
- Study ID
- NCT07691008
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Hematopoietic Neoplasm
- Hematopoietic and Lymphatic System Neoplasm
- Lymphatic System Neoplasm
- Malignant Solid Neoplasm
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Non-Interventional Study — OTHERNon-Interventional Study
Study Details
This study receives physiological and lifestyle-related data from mobile phones to create an institutional database.
Key Dates
- First listed
- Jul 8, 2026
- Start date
- Dec 1, 2026
- Status verified
- Jul 2026
- Primary completion
- Dec 1, 2028
- Completion
- Dec 1, 2034
Study Design
- Enrollment
- 1,200 participants (estimated)
Arms
- Arm: ObservationalParticipants have health data collected from their mobile phone for up to 5 years throughout the study.
Primary Outcome Measure
Feasibility of data collection [ Time Frame: Up to 8.5 years ]
Central Contacts
- Lee Jones626-761-2214
Related Studies
- Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton TherapyRecruiting · M.D. Anderson Cancer Center · Houston, Texas
- Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial CancerRecruiting · University of Washington · Seattle, Washington
- Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy ProgramRecruiting · M.D. Anderson Cancer Center · Houston, Texas
- Project: Every Child for Younger Patients With CancerRecruiting · Children's Oncology Group · Birmingham, Alabama